Skip to main content
SpringerLink
Log in

Zur Infektionssicherheit des Fibrinklebers Tissucol

  • Chapter
Technik der Fibrinklebung in der endoskopischen Chirurgie

Zusammenfassung

Gerade bei einem Präparat, das so häufig und vielfältig eingesetzt wird wie der Fibrinkleber Tissucol, ist die Infektionssicherheit von höchster Bedeutung. Seit seiner Markteinführung wurde im Verlauf millionenfacher Anwendung kein einziger Fall einer Infektionsübertragung durch Tissucol bekannt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Aach RD, Szmuness W, Mosley JW, Hollinger FB, Kahn RA, Stevens CE, Edwards VM, Werch J (1981) Serum alanine aminotransferase of donors in relation to the risk of non A, non B hepatitis in recipients.New Engl J Med 304: 989–994

    Article  PubMed  CAS  Google Scholar 

  2. Alter HJ, Purcell RH, Holland PV, Alling DW, Koziol DE (1981) Donor transaminase and recipient hepatitis.JAMA 246: 630–634

    Article  PubMed  CAS  Google Scholar 

  3. Barrett N, Dorner F, Wöber G, Eibl J (1989) Inactivation of the human immunodeficiency viruses (HIV-1 and HIV-2) by steam treatment of human blood products. 12th Congress of the International Society on Thrombosis and Haemostasis, Tokyo, Japan. Thromb Haemost 62: 454

    Google Scholar 

  4. Cuthbertson B, Rennie JG, Aw D, Reid KG (1987) Safety of albumin preparations manufactured from plasma not tested for HIV antibody. Lancet 11: 41

    Article  Google Scholar 

  5. Eder G, Neumann M, Cerwenka R, Baumgarten K (1986) Preliminary results of a ran-domized controlled study on the risk of hepatitis transmission of a two-component fibrin sealant (Tissucol/Tisseel). In: Schlag G, Redl H (eds) Fibrin sealant in operative medicine, vols 1–7. Springer, Berlin Heidelberg New York Tokyo, pp 51–59

    Chapter  Google Scholar 

  6. Köhler M, Hellstern P, Wenzel E, Blohn G von (1989) Factor VII half-life after transfusion of a steam-treated factor VII concentrate in a patient with homozygous factor VII deficiency.Vox Sang 56: 200–201

    Article  PubMed  Google Scholar 

  7. Mannucci PM, Schimpf KI, Abe T et al. and the International Investigator Group (1992) Low risk of viral infection after administration of vapor-heated factor VIII concentrate.Transfusion 32: 134–138

    Article  PubMed  CAS  Google Scholar 

  8. McDougal JS, Martin LS, Mozen CM, Heldebrant CM, Evatt BL (1985) Thermal inactiva-tion of the acquired immunodeficiency syndrome virus, human T lymphotropic virus- III/lymphadenopathy-associated virus, with special reference to antihemophilic factor.J Clin Invest 76: 875–877

    Article  PubMed  CAS  Google Scholar 

  9. Panis R, Scheele J (1981) Hepatitisrisiko bei der Fibrinklebung in der HNO-Chirurgie.Laryng Rhinol Otol 60: 367–368

    Article  CAS  Google Scholar 

  10. Popovic M, Sarngadharan MG, Read E, Gallo RC (1984) Detection, isolation and con-tinuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.Science 224: 497–500

    Article  PubMed  CAS  Google Scholar 

  11. Preiss D, Eberspächer B, Abdullah D, Rosner I (1991) Safety of vapour heated prothrombin complex concentrate (PCC) prothromplex S-TIM 4.Thromb Res 63: 651–659

    Article  PubMed  CAS  Google Scholar 

  12. Rousou J, Levitsky S, Gonzalez-Lavin L et al. (1989) Randomized clinical trial of fibrin sealant in patients undergoing resternotomy of reoperation after cardiac operations.J Thorac Cardiovasc Surg 97: 194–203

    PubMed  CAS  Google Scholar 

  13. Scheele J, Schricker T, Goy RO, Lampe I, Panis R (1981) Hepatitisrisiko der Fibrinklebung in der Allgemeinchirurgie.Med Welt 32: 783–788

    PubMed  CAS  Google Scholar 

  14. Schimpf K (1987) Klinische Studien zur Infektiosität von konventionellen und virusinakti-vierten Gerinnungsfaktorenkonzentraten. In: Landbeck G, Schimpf K (Hrsg) 3. Rundtisch-gespräch über aktuelle Probleme der Substitutionstherapie Hämophiler. Springer, Berlin Heidelberg New York Tokyo, S 69–79

    Chapter  Google Scholar 

  15. Schimpf K (1988) Substitutionstherapie bei angeborenen Gerinnungsstörungen. In: Just OH, Krier C (Hrsg) Hämostase in Anästhesie und Intensivmedizin. Springer, Berlin Hei-delberg New York Tokyo, S 17–28

    Google Scholar 

  16. Shapiro A, Abe T, Aledort L et al. and the International Factor Study Group (1992) A study to determine the safety of virus inactivated factor concentrates in patients with factor VII and IX deficiency native to blood product administration. XX International Congress of the World Federation of Hemophilia, Athen (12. –17.10.)

    Google Scholar 

  17. Spire B, Dormont D, Barre-Sinoussi F, Montagnier L, Chermann JC (1985) Inactivation of lymphadenopathy-associated virus by heat, gamma rays, and ultraviolet light.Lancet 1: 188–189

    Article  PubMed  CAS  Google Scholar 

  18. Sugg U (1985) Risiko der Hepatitisübertragung durch humanen Fibrinkleber.Dtsch Med Wochenschr 110: 1161–1162

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. B. König
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N. Dum
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Odar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. Schosser
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Abteilung Endoskopie, Klinikum der Stadt Mannheim, Theodor-Kutzer-Ufer, 68167, Mannheim, Germany

    B. C. Manegold

  2. Abteilung Chirurgie, Akademisches Lehrkrankenhaus der Freien Universität Berlin, Schloßparkklinik Heubnerweg 2, 14059, Berlin, Germany

    Volker Lange

  3. Chirurgische Universitätsklinik, Universität Freiburg, Hugstetterstraße 50, 79106, Freiburg, Germany

    Richard Salm

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

König, B., Dum, N., Odar, J., Schosser, R. (1994). Zur Infektionssicherheit des Fibrinklebers Tissucol. In: Manegold, B.C., Lange, V., Salm, R. (eds) Technik der Fibrinklebung in der endoskopischen Chirurgie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77414-0_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-77414-0_2

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-55336-6

  • Online ISBN: 978-3-642-77414-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation